Evidence mapPaperPMID 42438639Full record

ReviewCureus2026

The Gastro-Circadian Metabolic Axis: A Comprehensive Framework for Chronotherapy in Gastroenterology.

Mohammed Alkhaldi, Alejandra Felix Vicente, Victoria Fansey, Rachel Melissa Salins, Ahmad Mahmoo, Mariam Alamgir, Ann Maria Dominic, Mohamed Izzeldin S Siddig, Cheree Suk, Quratul Ain Haider and 2 more

Abstract readReview
In one paragraph

Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mohammed AlkhaldiInternal Medicine, University College Dublin, Dublin, GBR.
Alejandra Felix VicenteInternal Medicine, Universidad de Sonora, Hospital Infantil del Estado de Sonora, Sonora, MEX.
Victoria FanseyGeneral Medicine, University of Nis, Nis, SRB.
Rachel Melissa SalinsGeneral Medicine, Kasturba Medical College, Mangalore, IND.
Ahmad MahmooGeneral Surgery, Xinjiang Medical University, Xinjiang, CHN.
Mariam AlamgirMedicine, Washington State University, Washington, USA.
Ann Maria DominicInternal Medicine, St. John's Medical College Hospital, Bangalore, IND.
Mohamed Izzeldin S SiddigInternal Medicine, South Tees University Hospital, Middlesborough, GBR.
Cheree SukInternal Medicine, Kyungpook National University School of Medicine, Daegu, KOR.
Quratul Ain HaiderInternal Medicine, Poonch Medical College, Rawalakot, PAK.
Jocelyn N WenselInternal Medicine, International University of Health Sciences, Basseterre, KNA.
Manju RaiBiotechnology, Shri Venkateshwara University, Gajraula, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circadian rhythms exert fundamental control over gastrointestinal and metabolic physiology, governing 24-hour patterns of motility, secretion, nutrient absorption, microbial activity, immune regulation, and hepatic metabolism. Accumulating evidence indicates that the gastrointestinal tract is not an isolated system but is tightly integrated with systemic metabolic and neuroendocrine networks, forming a coordinated gastro-circadian metabolic axis (GCMA). This axis links molecular clocks in the gut, liver, adipose tissue, and skeletal muscle with rhythmic inputs from the gut microbiome, feeding-fasting cycles, autonomic signaling, and enteroendocrine mediators. Disruption of circadian alignment, through shift work, sleep deprivation, irregular meal timing, or nocturnal light exposure, leads to desynchronization between central and peripheral clocks, promoting inflammation, impaired epithelial barrier function, dysbiosis, altered bile acid signaling, insulin resistance, and disturbed energy homeostasis. These mechanisms contribute to a wide spectrum of gastrointestinal disorders, including gastroesophageal reflux disease, functional dyspepsia, irritable bowel syndrome, metabolic dysfunction-associated steatotic liver disease, inflammatory bowel disease, and potentially gastrointestinal malignancies. This review synthesizes molecular, translational, and clinical evidence to position the GCMA as a unifying framework for understanding circadian influences on digestive and metabolic disease. Importantly, it highlights emerging therapeutic opportunities in chronotherapy, including time-optimized pharmacotherapy, chrononutrition, and microbiota-targeted interventions. While current translation is limited by interindividual chronotype variability and heterogeneous clinical evidence, advances in wearable circadian monitoring, multi-omics profiling, and computational modeling offer promising avenues for precision implementation. Integrating GCMA principles into clinical practice may improve disease outcomes and establish circadian alignment as a cornerstone of preventive and therapeutic gastroenterology.

Indexed as

chrononutritionchronotherapycircadian rhythmsgastro-circadian metabolic axisgastrointestinal disordersgut microbiomemetabolic homeostasistime-restricted feeding

Identifiers

PMID42438639
PMCPMC13356768

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.